Literature DB >> 18056727

Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review.

Elena Meseguer1, Julien Labreuche, Jeam Marc Olivot, Halim Abboud, Philippa C Lavallee, Olivier Simon, Lucie Cabrejo, Amaya Echeverria, Isabelle F Klein, Mikael Mazighi, Pierre Amarenco.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18056727     DOI： 10.1093/ageing/afm177

Source DB:  PubMed          Journal:  Age Ageing        ISSN： 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  12 in total

1.  Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥ 80 years of age.

Authors:  Gregoire Boulouis; Frederic Dumont; Charlotte Cordonnier; Marie Bodenant; Didier Leys; Hilde Hénon
Journal:  J Neurol       Date:  2011-12-20       Impact factor: 4.849

2.  Navigating the gray zones of stroke management for a graying population.

Authors:  Meng Lee; Bruce Ovbiagele
Journal:  Cerebrovasc Dis       Date:  2010-03-30       Impact factor: 2.762

Review 3.  Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients.

Authors:  Laurent Derex; Norbert Nighoghossian
Journal:  Nat Rev Neurol       Date:  2009-08-04       Impact factor: 42.937

Review 4.  Ischemic stroke in the elderly: an overview of evidence.

Authors:  Ruo-Li Chen; Joyce S Balami; Margaret M Esiri; Liang-Kung Chen; Alastair M Buchan
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

5.  Intravenous tissue plasminogen activator and stroke in the elderly.

Authors:  W T Longstreth; Ronit Katz; David L Tirschwell; Mary Cushman; Bruce M Psaty
Journal:  Am J Emerg Med       Date:  2010-03       Impact factor: 2.469

6.  [Baseline predictors of outcome in stroke patients treated with intravenous thrombolysis--the Austrian stroke unit registry].

Authors:  Raffi Topakian; Hans-Peter Haring; Franz T Aichner
Journal:  Wien Med Wochenschr       Date:  2008

Review 7.  Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.

Authors:  Hakan Sarikaya
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

8.  Age dependency of safety and outcome of endovascular therapy for acute stroke.

Authors:  Rudolf Luedi; Kety Hsieh; Agnieszka Slezak; Marwan El-Koussy; Urs Fischer; Mirjam R Heldner; Julia Meisterernst; Marie-Luise Mono; Christoph Zubler; Pasquale Mordasini; Christoph Ozdoba; Heinrich P Mattle; Gerhard Schroth; Jan Gralla; Marcel Arnold; Simon Jung
Journal:  J Neurol       Date:  2014-06-11       Impact factor: 4.849

9.  Professional guideline versus product label selection for treatment with IV thrombolysis: An analysis from SITS registry.

Authors:  Alan C Cameron; James Bogie; Azmil H Abdul-Rahim; Niaz Ahmed; Michael Mazya; Robert Mikulik; Werner Hacke; Kennedy R Lees
Journal:  Eur Stroke J       Date:  2017-12-08

10.  The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era.

Authors:  Shunsaku Takayanagi; Takashi Ochi; Shunya Hanakita; Yasutaka Suzuki; Keiichiro Maeda
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-03-27       Impact factor: 1.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.